HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esophageal Crohn's disease treated successfully with adalimumab.

AuthorsLola Y Kwan, Jeffrey L Conklin, Konstantinos A Papadakis
JournalInflammatory bowel diseases (Inflamm Bowel Dis) Vol. 13 Issue 5 Pg. 639-40 (May 2007) ISSN: 1078-0998 [Print] England
PMID17221856 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab
Topics
  • Adalimumab
  • Adult
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Crohn Disease (diagnosis, drug therapy)
  • Esophageal Diseases (diagnosis, drug therapy)
  • Esophagoscopy
  • Female
  • Humans
  • Tumor Necrosis Factor-alpha

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: